À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÔÚÃÀ¹úFDA¿ìËÙͨµÀÌõ¼þÏÂÍê³É¹ö¶¯Ìá½»ÖÎÁÆÔçÆÚ°¢¶û´Äº£Ä¬²¡ÂØ¿¨Ä¹Î¬³Ö¼ÁÁ¿µÄÉúÎïÖÆÆ·Ðí¿ÉÉêÇë
À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ºÍ²³½¡Ðû²¼£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÒÑÍê³ÉÏòÃÀ¹úʳƷҩƷ¹ÜÀí¾Ö£¨FDA£©¹ö¶¯Ìá½»ÂØ¿¨Ä¹£¨lecanemab-irmb£©£¨ÃÀ¹úÉÌÆ·Ãû£ºLEQEMBI?£¬ÖйúÉÌÆ·Ãû£ºÀÖÒâ±£?£©Ã¿ÖÜά³Ö¼ÁÁ¿µÄÉúÎïÖÆÆ·Ðí¿ÉÉêÇ루BLA£©¡£